High expression of L-type amino acid transporter 1 in infiltrating glioma cells

被引:57
|
作者
Nawashiro H. [1 ]
Otani N. [1 ]
Uozumi Y. [1 ]
Ooigawa H. [1 ]
Toyooka T. [1 ]
Suzuki T. [1 ]
Katoh H. [1 ]
Tsuzuki N. [1 ]
Ohnuki A. [1 ]
Shima K. [1 ]
Shinomiya N. [2 ]
Matsuo H. [3 ]
Kanai Y. [4 ]
机构
[1] Department of Neurosurgery, National Defense Medical College, Tokorozawa, Saitama 359-8513
[2] Department of Microbiology, National Defense Medical College, Saitama
[3] 1st Department of Physiology, National Defense Medical College, Saitama
[4] Department of Pharmacology and Toxicology, Kyorin University, School of Medicine, Tokyo
关键词
Glioma; Immunohistochemistry; LAT1;
D O I
10.1007/s10014-005-0188-z
中图分类号
学科分类号
摘要
L-type amino acid transporter 1 (LAT1), a neutral amino acid transport agent, is essential for the transport of large neutral amino acids. LAT1 also corresponds to tumor-associated gene-1 (TA1), an oncofetal antigen that is expressed primarily in fetal tissues and cancer cells such as glioma cells. We have investigated the expression of the transporter in the human primary glioma tissue from 68 patients. Among these patients, we could see the border zone between tumors and normal bain tissues in 10 patients. By WHO criteria, two of the specimens were diagnosed as grade 2, three as grade 3, and five as grade 4 [glioblastoma multiforme (GBM)]. In 9 of 10 cases, we could identify the infiltrating glioma cells associated with stronger immunoreactivity for LAT1. These tumor cells aggregated around the neurons in the border zone and were often found in the perivascular space. In one GBM case, the tumors seemed to develop expansively and separated from the normal brain with a border of arachnoid membrane. The expression of LAT1 was always higher in infiltrating glioma cells than in cells located in the center of the tumor. These findings suggest that LAT1 is one of the molecular targets for glioma therapy. © 2005 The Japan Society of Brain Tumor Pathology.
引用
收藏
页码:89 / 91
页数:2
相关论文
共 50 条
  • [31] Involvement of L-type amino acid transporter 1 in the development of intestinal tumors
    Sui, Yunlong
    Hoshi, Namiko
    Ohgaki, Ryuichi
    Ito, Yuki
    Kotani, Takenori
    Matozaki, Takashi
    Kodama, Yuzo
    CANCER SCIENCE, 2023, 114 : 1832 - 1832
  • [32] METHYLMERCURY-L-CYSTEINE TARGETING L-TYPE AMINO ACID TRANSPORTER CONJUGATE CYTOTOXICITY ON C6 GLIOMA CELLS
    Wei, Z. Y.
    Feng, M. M.
    Yang, B.
    Yan, Z. Y.
    Wang, B. Q.
    Bu, X. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (01): : 147 - 151
  • [33] Genetic and Functional Study of L-Type Amino Acid Transporter 1 in Schizophrenia
    Comasco, Erika
    Vumma, Ravi
    Toffoletto, Simone
    Johansson, Jessica
    Flyckt, Lena
    Lewander, Tommy
    Oreland, Lars
    Bjerkenstedt, Lars
    Andreou, Dimitrios
    Soderman, Erik
    Terenius, Lars
    Agartz, Ingrid
    Jonsson, Erik G.
    Venizelos, Nikolaos
    NEUROPSYCHOBIOLOGY, 2016, 74 (02) : 96 - 103
  • [34] High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas
    Yanagisawa, Nobuyuki
    Ichinoe, Masaaki
    Mikami, Tetuo
    Nakada, Norihiro
    Hana, Kiyomi
    Koizumi, Wasaburo
    Endou, Hitoshi
    Okayasu, Isao
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (11) : 1019 - 1023
  • [35] L-type amino acid transporter 1 expression in prostate cancer: Association with cancer progression and high-grade malignancy
    Satoh, Takefumi
    Sakata, Takeshi
    Okayasu, Isao
    Ferdous, Golam
    Tsuruta, Tomoko
    Muto, Tomoko
    Ueno, Akinori
    Kanai, Yoshikatsu
    Endou, Hitoshi
    Baba, Shiro
    JOURNAL OF UROLOGY, 2008, 179 (04): : 105 - 105
  • [36] Involvement of L-type amino acid transporter 1 in the transport of gabapentin into human placental choriocarcinoma cells
    Furugen, Ayako
    Ishiguro, Yuri
    Kobayashi, Masaki
    Narumi, Katsuya
    Nishimura, Ayako
    Hirano, Takeshi
    Iseki, Ken
    REPRODUCTIVE TOXICOLOGY, 2017, 67 : 48 - 55
  • [37] Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors
    Kaira, Kyoichi
    Nakamura, Kazuto
    Hirakawa, Takashi
    Imai, Hisao
    Tominaga, Hideyuki
    Oriuchi, Noboru
    Nagamori, Shushi
    Kanai, Yoshikatsu
    Tsukamoto, Norifumi
    Oyama, Tetsunari
    Asao, Takayuki
    Minegishi, Takashi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (06): : 1161 - 1171
  • [38] Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
    Isoda, Atsushi
    Kaira, Kyoichi
    Iwashina, Masanori
    Oriuchi, Noboru
    Tominaga, Hideyuki
    Nagamori, Shushi
    Kanai, Yoshikatsu
    Oyama, Tetsunari
    Asao, Takayuki
    Matsumoto, Morio
    Sawamura, Morio
    CANCER SCIENCE, 2014, 105 (11) : 1496 - 1502
  • [39] The relationship between the L-type amino acid transporter 1 expression and clinical features in resectable pancreatic cancer
    Zhao, W. G.
    Fang, X.
    Li, Y.
    Kang, D. M.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (02): : 379 - 388
  • [40] Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma
    Maihulan Maimaiti
    Shinichi Sakamoto
    Yasutaka Yamada
    Masahiro Sugiura
    Junryo Rii
    Nobuyoshi Takeuchi
    Yusuke Imamura
    Tomomi Furihata
    Keisuke Ando
    Kosuke Higuchi
    Minhui Xu
    Tomokazu Sazuka
    Kazuyoshi Nakamura
    Atsushi Kaneda
    Yoshikatsu Kanai
    Natasha Kyprianou
    Yuzuru Ikehara
    Naohiko Anzai
    Tomohiko Ichikawa
    Scientific Reports, 10